Press Release: Mesenbio raises £1.4M to develop therapeutic pipeline

We are thrilled to announce an exciting development at Mesenbio — our recent fundraise through a successful Innovate UK Biomedical Catalyst grant and matched funding from Investors NG Bio and DSW Ventures.

This marks a truly exhilarating time for our team and our supporters. Our journey has been fueled by passion and innovation, and this fundraise is a testament to the confidence and belief in our vision.

The funds raised will propel us into the next phase of growth and enable us to continue our mission with even greater resources. We're excited about the opportunities that lie ahead and are deeply grateful to our investors for sharing in our vision.

Stay tuned for more updates as we embark on this thrilling journey together!

Read the press releases below:

University of York: University spin-out company to tackle rheumatoid arthritis

DSW and NG Bio: DSW Ventures and NG Bio lead £1.4m investment into University of York spinout, Mesenbio Limited